Archives of Dermatological Research

, Volume 302, Issue 3, pp 183–189 | Cite as

Gingko biloba extract reduces VEGF and CXCL-8/IL-8 levels in keratinocytes with cumulative effect with epigallocatechin-3-gallate

  • Sandra Trompezinski
  • Marlène Bonneville
  • Ingrid Pernet
  • Alain Denis
  • Daniel Schmitt
  • Jacqueline Viac
Original Paper


In skin inflammation, vascular endothelial growth factor (VEGF) and CXCL-8/IL-8 play an important role and are produced by activated keratinocytes. Extracts from Ginkgo biloba leaves (GBE), widely used in phytotherapy, have been reported to exert antioxidant and anti-inflammatory properties in the skin. We therefore evaluated the effects of GBE on the release of VEGF and CXCL8/IL-8 by normal human keratinocytes (NHKs) activated by tumor necrosis factor α (TNFα). Moreover, as we previously showed that epigallocatechin-3-gallate (EGCG) reduces VEGF and CXCL8/IL-8 secretion in TNFα-activated NHKs, we also tested its effect in association with GBE. Our results showed that GBE exerted a potent inhibition on VEGF and CXCL8/IL-8 levels in activated cells. In association with EGCG, GBE down-regulated VEGF and CXCL8/IL-8 levels in a cumulative manner in TNFα-stimulated NHKs. These results suggest that GBE, alone or in association with EGCG may contribute to moderate inflammatory processes in skin diseases associated with angiogenesis.


Ginkgo biloba Normal human keratinocyte VEGF CXCL8/IL-8 Inflammation EGCG 



Bovine pituitary extract






Epidermal growth factor


Enzyme-linked immunosorbent assays


Ginkgo biloba extract




3-(4, 5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide


Normal human keratinocyte


Propylene glycol


Tumor necrosis factor α





We thank pediatric service (Tbis) of Edouard Herriot Hospital in Lyon for their cooperation in collecting skin biopsy samples.

Conflict of interest statement

The authors declare that they have no conflict of interest.


  1. 1.
    Baggiolini M, Dewald B, Moser B (1994) Interleukin-8 and related chemotactic cytokines—CXC and CC chemokines. Adv Immunol 55:97–179CrossRefPubMedGoogle Scholar
  2. 2.
    Ballaun C, Weninger W, Uthman A et al (1995) Human keratinocytes express the three major splice forms of vascular endothelial growth factor. J Invest Dermatol 104:7–10CrossRefPubMedGoogle Scholar
  3. 3.
    Castelli D, Colin L, Camel E et al (1998) Pretreatment of skin with a Ginkgo biloba extract/sodium carboxymethyl-beta-1, 3-glucan formulation appears to inhibit the elicitation of allergic contact dermatitis in man. Contact Dermat 38:123–126CrossRefGoogle Scholar
  4. 4.
    Cheung F, Yl Siow, Wz Chen et al (1999) Inhibitory effect of Ginkgo biloba extract on the expression of inducible nitric oxide synthase in endothelial cells. Biochem Pharmacol 58:1665–1673CrossRefPubMedGoogle Scholar
  5. 5.
    Defeudis FV, Papadopoulos V, Drieu K (2003) Ginkgo biloba extracts and cancer: a research area in its infancy. Fundam Clin Pharmacol 17:405–417CrossRefPubMedGoogle Scholar
  6. 6.
    Ferrara N, Davis-Smyth T (1997) The biology of vascular endothelial growth factor. Endocr Rev 18:4–25CrossRefPubMedGoogle Scholar
  7. 7.
    Frank S, Hubner G, Breier G et al (1995) Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing. J Biol Chem 270:12607–12613CrossRefPubMedGoogle Scholar
  8. 8.
    Fujiki H, Suganuma M, Okabe S et al (1999) Mechanistic findings of green tea as cancer preventive for humans. Proc Soc Exp Biol Med 220:225–228CrossRefPubMedGoogle Scholar
  9. 9.
    Gomaa AH, Yaar M, Eyada MM et al (2007) Lymphangiogenesis and angiogenesis in non-phymatous rosacea. J Cutan Pathol 34:748–753CrossRefPubMedGoogle Scholar
  10. 10.
    Huh H, Staba E (1992) The botany and chemistry of Ginkgo biloba L. J Herbs Spices Med Plants 1:92–124CrossRefGoogle Scholar
  11. 11.
    Juarez CP, Muino JC, Guglielmone H et al (2000) Experimental retinopathy of prematurity: angiostatic inhibition by nimodipine, ginkgo-biloba, and dipyridamole, and response to different growth factors. Eur J Ophthalmol 10:51–59PubMedGoogle Scholar
  12. 12.
    Kanowski S, Herrmann WM, Stephan K et al (1996) Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia. Pharmacopsychiatry 29:47–56CrossRefPubMedGoogle Scholar
  13. 13.
    Katiyar SK, Ahmad N, Mukhtar H (2000) Green tea and skin. Arch Dermatol 136:989–994CrossRefPubMedGoogle Scholar
  14. 14.
    Kim BH, Lee YS, Kang KS (2003) The mechanism of retinol-induced irritation and its application to anti-irritant development. Toxicol Lett 146:65–73CrossRefPubMedGoogle Scholar
  15. 15.
    Kim SJ (2001) Effect of biflavones of Ginkgo biloba against UVB-induced cytotoxicity in vitro. J Dermatol 28:193–199PubMedGoogle Scholar
  16. 16.
    Kwak WJ, Han CK, Son KH et al (2002) Effects of Ginkgetin from Ginkgo biloba Leaves on cyclooxygenases and in vivo skin inflammation. Planta Med 68:316–321CrossRefPubMedGoogle Scholar
  17. 17.
    Larsen CG, Anderson AO, Oppenheim JJ et al (1989) Production of interleukin-8 by human dermal fibroblasts and keratinocytes in response to interleukin-1 or tumour necrosis factor. Immunology 68:31–36PubMedGoogle Scholar
  18. 18.
    Lim H, Son KH, Chang HW et al (2006) Effects of anti-inflammatory biflavonoid, ginkgetin, on chronic skin inflammation. Biol Pharm Bull 29:1046–1049CrossRefPubMedGoogle Scholar
  19. 19.
    Lim H, Son KH, Chang HW et al (2006) Inhibition of chronic skin inflammation by topical anti-inflammatory flavonoid preparation, Ato Formula. Arch Pharm Res 29:503–507CrossRefPubMedGoogle Scholar
  20. 20.
    Longuet-Perret I, Schmitt D, Viac J (1998) Tumour necrosis factor-alpha is involved in the contrasting effects of ultraviolet B and ultraviolet A1 radiation on the release by normal human keratinocytes of vascular permeability factor. Br J Dermatol 138:221–224CrossRefPubMedGoogle Scholar
  21. 21.
    Mahadevan S, Park Y (2008) Multifaceted therapeutic benefits of Ginkgo biloba L.: chemistry, efficacy, safety, and uses. J Food Sci 73:R14–R19PubMedCrossRefGoogle Scholar
  22. 22.
    Mizuno M, Mt Droy-Lefaix, Packer L (1996) Gingko biloba extract EGb 761 is a suppresser of AP-1 transcription factor stimulated by phorbol 12-myristate 13-acetate. Biochem Mol Biol Int 39:395–401PubMedGoogle Scholar
  23. 23.
    Neufeld G, Cohen T, Gengrinovitch S et al (1999) Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13:9–22PubMedGoogle Scholar
  24. 24.
    Nishida S, Satoh H (2003) Mechanisms for the vasodilations induced by Ginkgo biloba extract and its main constituent, bilobalide, in rat aorta. Life Sci 72:2659–2667CrossRefPubMedGoogle Scholar
  25. 25.
    Parsad D, Pandhi R, Juneja A (2003) Effectiveness of oral Ginkgo biloba in treating limited, slowly spreading vitiligo. Clin Exp Dermatol 28:285–287CrossRefPubMedGoogle Scholar
  26. 26.
    Pernet I, Sagot V, Schmitt D et al (1999) UVA1 and UVB radiation but not PGE2 stimulate IL-8 release in normal human keratinocytes. Arch Dermatol Res 291:527–529CrossRefPubMedGoogle Scholar
  27. 27.
    Pietrzak AT, Zalewska A, Chodorowska G et al (2008) Cytokines and anticytokines in psoriasis. Clin Chim Acta 394:7–21CrossRefPubMedGoogle Scholar
  28. 28.
    Rimbach G, Gohil K, Matsugo S et al (2001) Induction of glutathione synthesis in human keratinocytes by Ginkgo biloba extract (EGb761). Biofactors 15:39–52CrossRefPubMedGoogle Scholar
  29. 29.
    Rosenberger C, Solovan C, Rosenberger AD et al (2007) Upregulation of hypoxia-inducible factors in normal and psoriatic skin. J Invest Dermatol 127:2445–2452CrossRefPubMedGoogle Scholar
  30. 30.
    Sagar SM, Yance D, Wong RK (2006) Natural health products that inhibit angiogenesis: a potential source for investigational new agents to treat cancer-Part 1. Curr Oncol 13:14–26PubMedGoogle Scholar
  31. 31.
    Smith JR, Lanier VB, Braziel RM et al (2007) Expression of vascular endothelial growth factor and its receptors in rosacea. Br J Ophthalmol 91:226–229CrossRefPubMedGoogle Scholar
  32. 32.
    Takematsu H, Tagami H (1993) Mode of release of interleukin-8 from proliferating human epidermal keratinocytes in vitro. Exp Dermatol 2:121–124CrossRefPubMedGoogle Scholar
  33. 33.
    Trompezinski S, Denis A, Schmitt D et al (2003) Comparative effects of polyphenols from green tea (EGCG) and soybean (genistein) on VEGF and IL-8 release from normal human keratinocytes stimulated with the proinflammatory cytokine TNFalpha. Arch Dermatol Res 295:112–116CrossRefPubMedGoogle Scholar
  34. 34.
    Trompezinski S, Pernet I, Schmitt D et al (2001) UV radiation and prostaglandin E2 up-regulate vascular endothelial growth factor (VEGF) in cultured human fibroblasts. Inflamm Res 50:422–427CrossRefPubMedGoogle Scholar
  35. 35.
    Viac J, Palacio S, Schmitt D et al (1997) Expression of vascular endothelial growth factor in normal epidermis, epithelial tumors and cultured keratinocytes. Arch Dermatol Res 289:158–163CrossRefPubMedGoogle Scholar
  36. 36.
    Wei Z, Peng Q, Bh Lau et al (1999) Ginkgo biloba inhibits hydrogen peroxide-induced activation of nuclear factor kappa B in vascular endothelial cells. Gen Pharmacol 33:369–375CrossRefPubMedGoogle Scholar
  37. 37.
    Xia YP, Li B, Hylton D et al (2003) Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis. Blood 102:161–168CrossRefPubMedGoogle Scholar
  38. 38.
    Yang PY, Rui YC, Zhang L et al (2002) Expression of vascular endothelial growth factor in U937 foam cells and the inhibitory effect of drugs. Yao Xue Xue Bao 37:86–89PubMedGoogle Scholar
  39. 39.
    Yoshikawa T, Naito Y, Kondo M (1999) Ginkgo biloba leaf extract: review of biological actions and clinical applications. Antioxid Redox Signal 1:469–480CrossRefPubMedGoogle Scholar
  40. 40.
    Zhang L, Rui YC, Yang PY et al (2002) Inhibitory effects of Ginkgo biloba extract on vascular endothelial growth factor in rat aortic endothelial cells. Acta Pharmacol Sin 23:919–923PubMedGoogle Scholar
  41. 41.
    Zheng SX, Zhou LJ, Chen ZL et al (2000) Bilobalide promotes expression of glial cell line-derived neurotrophic factor and vascular endothelial growth factor in rat astrocytes. Acta Pharmacol Sin 21:151–155PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  • Sandra Trompezinski
    • 1
    • 2
  • Marlène Bonneville
    • 3
  • Ingrid Pernet
    • 2
  • Alain Denis
    • 3
  • Daniel Schmitt
    • 1
  • Jacqueline Viac
    • 1
  1. 1.Université de Lyon, EA4169, Hôpital E. HerriotLyonFrance
  2. 2.DIPTA, 505, rue Pierre BerthierAix-en-ProvenceFrance
  3. 3.Laboratoire Dermatologique BiodermaLyonFrance

Personalised recommendations